I am thrilled to share that the first preprint from my lab is now available on bioRxiV! In this study, our team elucidates the role of autocrine ligands in the aberrant behavior of oncogene-driven lung cancer. www.biorxiv.org/content/10.1...

BRAFV600E-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling

Secretion of ligands of the human epidermal growth factor (EGFR) family of receptors or erythroblastic leukemia viral oncogene family (ERBB1-4) is a feature common to many cancer cells. However, our u...

biorxiv.org

Buckeroo Breakfast with Daddy today.

Our newest article is online @naturecancer.bsky.social A new antibody drug conjugate that doesn’t kill tumor cells but rely on immune system to eradicate cancer. @bettykimmdphd.bsky.social @mdanderson.bsky.social

An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy

Nature Cancer - Schrank et al. report the design and characterization of an antibody–toxin conjugate targeting CD47, promoting anti-tumor immunity in preclinical cancer models.

nature.com

A new generation of cancer-preventing vaccines could wipe out tumors before they form. Learn more on #WorldCancerDay: https://scim.ag/4gk8Qmo

Finishing up 2024 with our latest paper in Nature Rev Bioengineering on using multiomic tools to study bio-nano interactions. @bettykimmdphd.bsky.social @mdanderson.bsky.social

Multi-omics approaches to decipher the interactions of nanoparticles and biological systems - Nature Reviews Bioengineering

The interactions of nanoparticles with the body are dynamic and complex. This Perspective examines the application of different multi-omics tools to investigate nano–bio interactions in vitro and in v...

nature.com

Congrats Yifan on your publication today @natureBME Understanding nanoparticle interactions with biological systems with multi-omics approaches for clinical applications @bettykimmdphd.bsky.social @wenjiang-nano.bsky.social x.com/natrevbioeng...

My favorite time of the year @mdanderson.bsky.social Almost a mile on our #skybridge for our annual #wreathauction. Place your bids on your favorite wreath now! Thank you to all of our volunteers!

Our new tradition every Thanksgiving. watching Jim Allison: Breakthrough movie. Must-watch, especially students interested in science and medicine. Modern day #superman (cape missing) who saves millions of lives. Inspirational @jimallisonphd.bsky.social @pamsharmamdphd.bsky.social amzn.to/4gdxXaR

Grateful for this holiday season. Especially for our family, friends, mentors and our trainees who fills us with joy, love, laughter and kindness. Our first attempt at roasting a turkey finally became reality at 9pm. #Thankful #SomeonesSmoked&RaginCajunTurkiesWereBetter @wenjiang-nano.bsky.social

www.nature.com/articles/s41... Sharing our latest review article to highlight the importance of appropriately developing combination strategies for immune checkpoint therapy. Grateful for working with 3 brilliant scientists: Sangeeta Goswami, Kristen Pauken & Linghua Wang

Next-generation combination approaches for immune checkpoint therapy - Nature Immunology

In this Review, Sharma and colleagues describe the current landscape of combination therapies and discuss requirements for the development of effective combination strategies.

nature.com

Great time tonight with guest Dolores Hambardzumyan and our colleagues Jason Schenkel, @wenjiang-nano.bsky.social and #JPAI members @pamsharmamdphd.bsky.social @jimallisonphd.bsky.social Xi Chen @mdanderson.bsky.social #myeloid #GBM #endcancer

Here I am! Just discovered that I have 6 followers on Bluesky already with some of the most respected and nicest scientists I know.